Autophagy-related gene (Atg) 5 is a gene product required for the formation of autophagosomes. Here, we report that Atg5, in addition to the promotion of autophagy, enhances susceptibility towards apoptotic stimuli. Enforced expression of Atg5-sensitized tumour cells to anticancer drug treatment both in vitro and in vivo. In contrast, silencing the Atg5 gene with short interfering RNA (siRNA) resulted in partial resistance to chemotherapy. Apoptosis was associated with calpain-mediated Atg5 cleavage, resulting in an amino-terminal cleavage product with a relative molecular mass of 24,000 (M r 24K). Atg5 cleavage was observed independent of the cell type and the apoptotic stimulus, suggesting that calpain activation and Atg5 cleavage are general phenomena in apoptotic cells. Truncated Atg5 translocated from the cytosol to mitochondria, associated with the anti-apoptotic molecule Bcl-x L and triggered cytochrome c release and caspase activation. Taken together, calpain-mediated Atg5 cleavage provokes apoptotic cell death, therefore, represents a molecular link between autophagy and apoptosis -a finding with potential importance for clinical anticancer therapies.
Autophagy is a highly conserved process that occurs in yeast, plants and in mammalian cells. By means of autophagy, the cell keeps a constant balance between biosynthetic and catabolic processes, which also include the degradation of entire organelles. A portion of the cytoplasm is sequestered in an autophagosome and its contents are degraded on fusion with lysosomes 1, 2 . Although autophagy promotes a cell-survival response 3 , morphological features of autophagy have also been observed in dying cells, where caspases (key enzymes in the process of apoptosis) were suppressed or not sufficiently activated. Therefore, autophagic cell death has been considered as a "fail-safe" mechanism under conditions in which apoptosis does not work 4, 5 . Thus, a switch from apoptosis to autophagic cell death can occur. However, whether autophagy could promote apoptosis was not known.
The process of autophagosome formation is regulated by several autophagy genes (Atgs) 1, 2 . Atg5-(ref. 6) or Atg6-(also known as Beclin-1) 7, 8 deficient mouse embryonic stem cells contain decreased numbers of autophagic vesicles, suggesting that at least some Atgs are essential for autophagy. We were interested in the effect of elevating Atg5 levels in cells and used two techniques for this purpose: first, HeLa cells were stably transfected with the GFP-tagged full-length human Atg5 (NCBI; accession number, 12803724), GFP-tagged cytochrome c 9 , GFP-tagged microtubule-associated protein light chain (LC3, Atg8) or no insert. Second, Jurkat cells received Atg5 using lentiviral gene transfer. As control, the same vector with a GFP cDNA insert was used. In both systems, isolated exogenous Atg5 gene transfer resulted in cells exhibiting signs of increased autophagy (see Supplementary Information, Fig. S1 ).
We next investigated whether elevated Atg5 levels and subsequent increased autophagic activity were associated with changes in the susceptibility of cells to undergo death receptor-mediated or stress-mediated death. Compared with GFP-transfected (or untransfected) cells, an increased susceptibility to undergo death was observed in cells with enforced expression of Atg5. Atg5 sensitized cells to CD95-, ceramide-and anticancer drug-(etoposide and doxorubicin) mediated cell death, independent of the cell type. As an additional control, LC3 was overexpressed in HeLa cells and no increased susceptibility to death was observed (Fig. 1a) . Increased Atg5 levels were also associated with increased caspase-3 activity after CD95 stimulation of HeLa cells, as well as with increased apoptotic morphology and phosphatidylinositol redistribution within the plasma membrane in anti-CD95 antibody and staurosporine treated Jurkat cells, suggesting that the type of death was apoptosis (Fig. 1b, c) .
To further understand the requirement for Atg5 in induction of apoptosis, Atg5 levels were reduced using short interfering RNA (siRNA; Fig. 1d ). Atg5-deficient HeLa and breast cancer MDA-MA-231 cells exhibited markedly reduced sensitivity towards the cytotoxic agents staurosporine and doxorubicin, respectively. It should be noted, however, that Atg5-deficient cells die in long-term cultures (5-7 days), possibly due to insufficient removal of defective cell organelles that may G F P + a n t i-C D 9 5 A t g 5 + a n t i-C D 9 5
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A t g 5 + e t o p o s id e G F P A t g 5 G F P + a n t i-C D 9 5 A t g 5 + a n t i-C D 9 5 accumulate in cells with reduced autophagic activity 3 . In addition to these in vitro findings, we also obtained evidence for an apoptosis-sensitizing role forAtg5 in vivo (see Supplementary Information, Fig. S2 ).
To test the hypothesis that Atg5 has a role in apoptosis pathways, the model of spontaneous neutrophil apoptosis 10 was used in initial experiments. Interestingly, an additional anti-Atg5-reactive molecule with an M r of 24K was detected in blood neutrophils from healthy donors that had been cultured in the absence of survival factors for 7 h. In contrast, in the presence of the survival factor GM-CSF, the 24K protein was not detected within this time period. Moreover, when the 24K form appeared, full-length 33K Atg5 was markedly reduced. In 24 h neutrophil cultures, the anti-Atg5 antibody recognized the 24K protein only and the 33K protein was no longer detected (Fig. 2a) . Next, Jurkat cells were stimulated with an anti-CD95 antibody known to induce apoptosis in these cells. In this model, the 24K anti-Atg5-reactive molecule was rapidly detected (after 3 h stimulation) and its presence seemed to increase over time (Fig. 2b) .
Other apoptosis triggers and cell types were also used. For instance, apoptosis was induced by staurosporine in Jurkat, HL-60 and EOL cells. Within 5 h of apoptosis induction, the 24K protein, which was associated with caspase-3 cleavage, was detected by immunoblotting (see Supplementary Information, Fig. S3a ). In addition, anti-CD95 treatment for 5 h was associated with the appearance of the 24K protein in eosinophils and this was accompanied by cleavage of poly(ADP-ribose)polymerase (PARP), suggesting increased caspase-3 activity in these cells (see Supplementary Information, Fig. S3b ). Cycloheximide (CHX) or actinomycin D treatment caused, similarly to CD95 activation, the appearance of 24K Atg5 in Jurkat cells, making it unlikely that the molecule is newly synthesized during the process of apoptosis (Fig. 2b) . These data suggest that 33K Atg5 might be a target of one or more proteases that are activated during apoptosis, consistently resulting in a 24K fragment of Atg5, independent of the apoptotic stimulus or the type of cell.
To obtain direct evidence for the Atg5 cleaving protease in apoptotic cells, a cell-free system, in which functionally active caspases, cathepsins or calpains were incubated with in vitro translated 35 S-labelled fulllength Atg5, was used. Several effector and initiator caspases (Fig. 3a) , in addition to the cathepsins B and D (Fig. 3b) , were unable to process Atg5. However, Atg5 was cleaved by both calpain-1 and calpain-2 to a 24K fragment and this cleavage was blocked by three different calpain inhibitors (Fig. 3c) . To identify the calpain cleavage site in Atg5, recombinant Atg5 was digested with calpain and the products were sequenced by Edman degradation. The relative molecular mass of truncated Atg5, determined by mass spectrometry after HPLC selection, was 23.447K (Fig. 3d) . Cleavage of Atg5 occurred at Thr 193, suggesting that the 24K form of Atg5 represents an N-terminal fragment of the protein (Fig. 3e ). An Atg5 molecule carrying a six-amino-acid deletion surrounding the cleavage site (Atg5 ∆191-196 ) that was calpain-resistant was generated (Fig. 3f) .
To examine whether inhibition of calpains blocks Atg5 cleavage in intact cells undergoing apoptosis, blood neutrophils were incubated in the presence and absence of the calpain inhibitor ALLN, which inhibited both apoptosis (data not shown) and the occurrence of 24K Atg5 in untreated and anti-CD95-treated neutrophils (7 h cultures). Similarly, cleavage of Bax, which is a target of calpain 11, 12 , was blocked with ALLN, indicating successful calpain inhibition. In contrast with Atg5 and Bax, Atg6 (refs 7, 8) did not seem to be a target of proteases in this system (Fig. 3g) . The importance of calpain for Atg5 cleavage in intact cells was also demonstrated using HeLa cells lacking detectable amounts of the common 28K calpain subunit 13 . Calpain-deficient HeLa cells were generated using specific siRNA. In calpain-deficient cells, staurosporine treatment was not associated with Atg5 cleavage, confirming that calpain is indeed the protease responsible (Fig. 3h) .
As enzymatic inhibition of calpain blocked neutrophil apoptosis 12 , we wanted to determine whether calpain-mediated cleavage of Atg5 was critical for apoptosis. Overexpression of Atg5 ∆191-196 in Atg5-deficient HeLa cells (treated with Atg5 siRNA, see Fig. 1d ), did not result in increased sensitivity to staurosporine (Fig. 3i) , suggesting that calpainmediated cleavage of Atg5 is a critical pro-apoptotic event in at least some forms of apoptosis.
To examine the possibility that the 24K N-terminal cleavage product of Atg5 regulates apoptosis, it was transiently overexpressed in HeLa cells. In cells overexpressing the 24K truncated form evidence for the induction of apoptosis was observed (nuclear condensation), although less efficiently compared with Bax (Fig. 4a ). In addition to nuclear condensation, 24K Atg5-induced cell death was associated with cytochrome c release into the cytosol, whereas, at least for a certain period of time, mitochondrial staining with Mitotracker orange was unchanged (Fig. 4b) . The ability of 24K Atg5 to induce apoptosis was not a consequence of cell detachment because more than 50% of the apoptotic cells expressing truncated Atg5 were still adherent. To further exclude the possibility that truncated Atg5 induces apoptosis as a consequence of cell rounding and detachment (anoikis), Jurkat cells were transfected with full-length and truncated Atg5 using a lentiviral transfection system (Fig. 4c) . Again, 24K Atg5 induced cell death in a time-dependent manner, whereas full-length Atg5 had no significant effect compared with GFP-transfected cells. Morphological changes were again observed in the 24K Atg5 transfected cells, which were consistent with apoptosis (Fig. 4c ). Overexpression of 24K Atg5 in CEM cells also resulted in rapid DNA fragmentation. However, in the presence of high levels of Bcl-2 (ref. 14), transfection of truncated Atg5 had only little death activity (Fig. 4d) . Interestingly, although Bcl-2-expressing CEM cells were largely protected from staurosporine-induced apoptosis, endogenous Atg5 was equally cleaved in these cells compared with control cells (Fig. 4e) . Therefore, cleavage of Atg5 is not necessarily associated with cell death and seems to occur within a pro-apoptotic pathway proximal to mitochondria.
To determine whether Atg5-mediated increased autophagy is required for increased susceptibility to apoptosis, HeLa cells with different levels of autophagic activity were examined. As expected, Atg5 siRNA treatment resulted in decreased autophagic activity and enforced Atg5 expression accelerated autophagy. Interestingly, calpainresistant Atg5
∆191-196 also stimulated autophagy, suggesting that calpain cleavage is not required for inducing autophagy. In contrast, overexpression of 24K Atg5 did not induce autophagy (Fig. 4f) . Transfection of the construct for 24K Atg5 in these different cells revealed that cell death occurs independently of autophagic activity (Fig. 4g) . Therefore, the autophagic activity of Atg5 does not seem to be required for the apoptotic effect of truncated Atg5. As 24K Atg5 induced cytochrome c release and apoptosis in different cell types not protected by high levels Bcl-2, we reasoned that truncated Atg5 would activate the mitochondrial death pathway and investigated whether Atg5 translocates to mitochondria when apoptosis was induced. Non-apoptotic and anti-CD95 antibody-stimulated HeLa cells were analysed by immunofluorescence staining and confocal microscopy. In non-apoptotic cells, Atg5 was observed in the cytosol and exhibited diffuse cellular staining with little mitochondrial localization detected. In contrast, after treatment with anti-CD95 T o t a l ly s a t e IP : a n t i-B a x IP : a n t i-B a x T o t a l ly s a t e T o t a l ly s a t e IP : a n t i-B c l-x antibodies, colocalization of Atg5 and the mitochondrial marker VDAC was observed, suggesting that either full-length or truncated Atg5 (or both) translocated to mitochondria (Fig. 5a ).
To identify the form of Atg5 translocating to mitochondria during apoptosis, we separated cytosol and membranes in neutrophils undergoing apoptosis and subsequently detected Atg5 by immunoblotting. The 24K Atg5 fragment associated with neutrophil apoptosis was first visible in the cytosol and subsequently appeared in the mitochondrial fraction, giving rise to the possibility that truncated Atg5, but not full-length Atg5, translocates to mitochondria. In addition, the appearance of 24K Atg5 in the mitochondrial fraction correlated with the detection of cytochrome c in the cytosol (Fig. 5b) .
To demonstrate that cytochrome c is released as a consequence of a physical interaction between mitochondria and truncated 24K Atg5, isolated mouse liver mitochondria were incubated with recombinant full-length 33K and truncated 24K Atg5. Truncated Bid (tBid) is know to permeabilize mitochondria and was therefore used as a positive control. The 24K form of Atg5 released cytochrome c from mitochondria in a concentration-dependent manner and similarly to tBid (Fig. 5c) . In contrast, full-length Atg5 released only little and almost undetectable amounts of cytochrome c in this system. We also observed that the 24K Atg5-mediated cytochrome c release was associated with caspase-3 cleavage (Fig. 5d) and that the induced apoptosis can be blocked by the pan-caspase inhibitor, z-VAD-fmk (data not shown). Together, these data suggest that the 24K Atg5 fragment translocates to mitochondria and releases, either alone or in concert with other pro-apoptotic proteins, cytochrome c to activate effector caspases.
To investigate whether truncated Atg5 may trigger cytochrome c release by binding to members of the Bcl-2 family, an immunoprecipitation-immunoblot analysis was performed in whole-cell lysates. In both non-apoptotic and staurosporine-treated (5 h) apoptotic Jurkat cells, full-length and truncated Atg5 did not seem to bind to Bax. In contrast, truncated Atg5, but not full-length Atg5, associated with Bcl-x L in apoptotic, but not in non-apoptotic, Jurkat cells (Fig. 5e ) -a finding that was confirmed in apoptotic HeLa cells and neutrophils (data not shown).
Thus, the possibility exists that truncated Atg5 promotes apoptosis by blocking the function of Bcl-x L leading to Bax activation. This type of mechanism has been described for some BH3-only proteins that inactivate Bcl-2-like survival proteins, which keep cells alive by inactivating Bax-Bak-like proteins 15 . However, it is not currently known whether binding of truncated Atg5 to Bcl-x L leads to Bcl-x L inactivation and subsequent activation of Bax-Baklike molecules. Clearly, further work is required to understand the precise mechanism of the apoptosis-promoting effect of truncated Atg5. Nevertheless, Atg5-induced death was blocked by high levels of expression of Bcl-2, supporting the hypothesis that truncated Atg5 targets mitochondria to release cytochrome c and perhaps other pro-apoptotic factors.
Direct death signalling through translocation to mitochondria has previously been reported for proteins not belonging to the Bcl-2 family. For instance, recent studies demonstrated that a fraction of p53 translocates to mitochondria during stress-induced apoptosis, but not during growth arrest 16, 17 . Similarly, no Atg5 cleavage and translocation was observed in non-proliferating viable cells. The mechanism of p53-mediated cytochrome c release involved, at least in part, the disruption of the Bax-Bcl- 22 have also been shown to translocate to mitochondria and to subsequently promote apoptosis.
The ubiquitous expression of both calpain and Atg5 suggests that the new intracellular death pathway described here is important for multiple cells in different lineages. Calpain has previously been described as being an upstream regulator of apoptosis that targets Bax, generating an M r 18K fragment with increased pro-apoptotic activity 11, 12 . Our observation of Atg5 cleavage in cells, independent of the apoptotic trigger, suggests that calpain activation is a general phenomenon associated with apoptosis. Moreover, at least in certain circumstances (for instance in drug-induced apoptosis), cleavage of Atg5 by calpain represents a critical pro-apoptotic event. Further work is required to understand how calpain is activated in the process of apoptosis.
In summary, we provide mechanistic insight into the functional roles of both calpain and Atg5 in regulating pro-apoptotic signalling pathways and report that cells with elevated amounts of Atg5 exhibit increased autophagic activity and increased likelihood to undergo apoptosis compared with normal cells. However, the increased death susceptibility mediated by Atg5 does not seem to be dependent on its capacity to induce autophagy. When cell death is inducted, Atg5 is used to promote apoptosis, which is mitochondria and caspasedependent. The data reported here have obvious ramifications for the treatment of cancer.
METHODS

Cells.
Isolations of blood neutrophils 23 , blood eosinophils 24 and bone marrowderived immature neutrophils 25, 26 were performed as previously described. Please see Supplementary ) were washed with PBS, lysed with modified RIPA-buffer (0.5% sodium deoxycholate, 1% NP40 in PBS) supplemented with a protease inhibitor-cocktail (Sigma) and 100 µM PMSF with frequent vortexing on ice for 30 min. Alternatively, cells were lysed with 2× loading buffer (Invitrogen, Paisley, UK) and sonicated. After a 10 min centrifugation step to remove insoluble particles, equal amounts of the cell lysates were loaded on NuPagegels. Separated proteins were electrotransferred onto PVDF membranes (Immobilion-P; Millipore, Bedford, MA). The filters were incubated with primary antibodies at 4 °C overnight in TBS, 0.1% Tween-20, 3% non-fat dry milk. The primary antibodies were: polyclonal anti-Atg5 (1:5000), polyclonal anti-caspase-3 (1:1000; BD Biosciences, Erembodegem, Belgium), polyclonal anti-PARP (1:1000; Cell Signaling, Danvers, MA), polyclonal anti-Beclin-1 (1:1000; Cell Signalling), monoclonal anti-GFP (1:5000; Becton Dickinson Biosciences), monoclonal anti-calpain (small subunit, clone P1, 1/1000; Chemicon International, Inc. Chandlers Ford, UK) and monoclonal anti-GAPDH (1/5000; Chemicon International). Filters were washed in TBS, 0.1% Tween-20 for 30 min and incubated with the appropriate HRP-conjugated secondary antibody (Amersham, Dübendorf, Switzerland) in TBS, 0.1% Tween-20, 5% non-fat dry milk for 1 h. Filters were developed by an ECL-technique (ECL-Kit, Amersham). In some experiments, immunoprecipitation was performed before immunoblotting (see Supplementary Information, Methods) .
Subcellular fractionation.
Freshly purified neutrophils were cultured for the indicated times, washed with cold PBS and digitonin-permeabilized essentially as previously described 27 . Equal amounts of proteins supplemented with NuPAGEloading buffer were loaded on 12% NuPAGE gels and subsequently transferred to PVDF membranes. Filters were incubated with polyclonal anti-Atg5 (1:5000), monoclonal anti-cytochrome c (1:5000; Becton Dickinson Biosciences) and monoclonal anti-VDAC (1:5000; Calbiochem-Novabiochem Corp., La Jolla, CA) antibodies.
Determination of cell death and apoptosis. Cell death was assessed by uptake of 1 µM ethidium bromide and flow cytometric analysis (FACS Calibur; Becton Dickinson, Heidelberg, Germany) 28 . To determine whether cell death was apoptosis, morphologic analysis using 10 µm Hoechst (Molecular Probes, Leiden, The Netherlands) or Diff-Quik (Baxter, Düdingen, Switzerland), as well as Annexin V staining 29 and DNA fragmentation 12,29 assays were performed. Caspase-3 activity was measured as enzymatic conversion of the colorimetric substrate Ac-DEVDpNA at 405 nm according to the manufacturer`s instructions (QuantiZyme caspase-3 cellular activity assay kit; Biomol International, Exeter, UK).
Determination of autophagic activity. Vacuolization and double membrane structures were analysed by transmission electron microscopy. Induction of autophagy was further demonstrated using GFP-LC3 (kind gift from T. Yoshimori, Osaka University, Osaka, Japan), which was expressed in HeLa cells. Cells were cultured under the indicated conditions and analysed by confocal microscopy and immunoblotting. The development of acidic vesicular organelles (AVOs), which correlates with autophagic activity, was also measured using the lysosomotropic fluorescent dye acridine orange and flow cytometry 30 .
In vitro protease cleavage assay. To directly determine which intracellular protease cleaved Atg5, 35 S-Atg5 or 35 S-Atg5 ∆191-196 were incubated (see below) with 4 U caspase-3, 4 U caspase-8, 0.5 U calpain-1, 0.5 U calpain-2, 0.1 U cathepsin B and 0.1 U cathepsin D in caspase buffer (50 mM HEPES at pH 7.4, 100 mM NaCl, 10% sucrose, 1 mM EDTA, 0.1% CHAPS, 10 mM DTT), cathepsin buffer (340 mM NaOAc, 60 mM acetic acid, 4 mM EDTA, 8 mM DTT, 0.1% CHAPS at pH 5.5) and calpain buffer (20 mM PIPES, 100 mM NaCl, 10 mM DTT, 0.1% CHAPS, 10% sucrose, 1 mM CaCl 2 at pH 7.2), respectively, at 37 °C for 1 h. 35 S-Bid served as positive control in the caspase and cathepsin experiments. The specificity of calpain action was controlled by using the following calpain inhibitors: E64-d (50 µM), calpastatin-derived peptide (10 µM), ALLN (10 µM). The reaction was stopped by adding loading buffer plus 1 mM DTT. Samples were heated at 90 °C for 5 min and subsequently analysed by SDS-PAGE followed by autoradiography.
Subcloning of truncated Atg5. For transduction of cells and the production of recombinant protein, the predicted cDNA of truncated Atg5 was cloned into pcDNA3 vector (Invitrogen), HIV-derived vector pWPT (gift from D. Trono, Swiss Institute of Technology (EFPL), Lausanne, Switzerland), pEGFP-N1 vector (Clontech, St-Germain-en-Laye, France) and pET-15b plasmid. The end sequence of truncated Atg5 was recognized by the following primer sequence: 5′-TCACGTTGTCTGATATATTCTAAAG-3′ (the underlined sequence represents an artificially introduced stop codon).
Lentiviral gene transfer.
Full-length and truncated Atg5 were subcloned into the HIV-derived vector pWPT, which contains a cytomegalovirus (CMV) promoter 32 . Stable Atg5 gene silencing was performed using pLVTHM (gift from D. Trono), a lentiviral vector for siRNA delivery 33 . Oligonucleotides suitable for siRNA experiments were designed against the mouse Atg5 sequence 5 . The calpain-resistant Atg5 ∆191-196 was generated using QuikChange site-directed mutagenesis kit (Stratagene Europe, Amsterdam, The Netherlands). To downregulate the small subunit of calpain (NM_001749) in HeLa cells, calpain-specific siRNAs in pLKO.1-puro were obtained from Sigma. For more information, please see Supplementary Information, Methods.
Confocal laser scanning microscopy. Cytospins were made from neutrophils on non-coated slides 12 . HeLa cells were allowed to grow overnight on washed coverslips. Indirect immunostainings for Atg5 and VDAC were performed at 4 °C overnight by using the following primary antibodies: Anti-Atg5 (1:100; diluted in blocking buffer) and anti-VDAC monoclonal antibody (1:50). Incubation with appropriate TRITC-and FITC-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Milan Analytica, La Roche, Switzerland) was performed in the dark at room temperature for 1 h. The slides were analysed by confocal microscopy (LSM 510, Carl Zeiss, Heidelberg, Germany). The scale bars shown in each photograph represent 10 µM.
For colocalization studies, unprocessed, unfiltered and undeconvoluted data sets were analysed using the Imaris software (Bitplane AG, Zurich, Switzerland), considering every singular layer of a stack separately. Quantitative data of colocalization events were determined by the statistics modules in the colocalization and Voxelshop software of the Imaris package. Intensities were given as sum of all colocalizing voxels in a data set and a computer image was generated. For quantitative analysis of colocalization, the Pearson's correlation coefficient was calculated 34 .
Analysis of the mitochondrial release of cytochrome c in vitro. Mitochondria were freshly isolated from the liver of 2-month-old mice 35 . Briefly, isolated mitochondria were incubated with 0.5 µM recombinant Bax and tBid, as well as with the indicated concentrations of the 24K and 33K forms of Atg5 at 37 °C for 1 h. After centrifugation at 20,000g for 15 min, the supernatants were analysed for the presence of cytochrome c by immunoblotting. To exclude the possibility of mitochondrial damage during isolation, the supernatant was also analysed after centrifugation of the mitochondria but before their incubation with recombinant proteins. Mitochondrial pellets were resuspended in lysis buffer and were additionally analysed by immunoblotting.
Statistical analysis. An analysis of variance test and Student's t-test were used to compare mean levels. P <0.05 was considered statistical significant. 
SUPPLEMENTARY INFORMATION
ATG5 GENE TRANSFER RESULTS IN INCREASED AUTOPHAGY
As analyzed by light microscopy, Atg5 overexpressing cells increased their cellular size. Moreover, the HeLa cells became more flat and in Jurkat cells, we observed vacuole-like structures. Atg5 was seen in the cytoplasm, mostly in the perinuclear area as determined by fluorescence analysis (Fig. S1a) . In addition, we analyzed these cells by transmission electron microscopy. 
ANTICANCER EFFECT OF ATG5 IN VIVO
Since Atg5 expression appeared to correlate with the susceptibility of cells to undergo anticancer drug-mediated apoptosis in vitro (see Fig. 1 Recombinant Atg5 was isolated and purified by Nickel column chromatography.
Fractions containing the protein were collected and digested with thrombin to remove the [His] 6 -tag. Protein quality was assessed by SDS-PAGE, and concentrations were calculated by amino acid analysis.
Calpain digestion of Atg5 was essentially performed as described before 31 .
Samples for Edman sequencing were prepared by blotting the separated cleavage products onto PVDF membranes and cutting out the bands corresponding to the fragments of interest. Fragments for mass spectrometry were isolated by HPLC.
Edman sequencing and mass spectrometry were performed at the Protein Service 
